HDAC6 inhibition is a promising therapeutic approach for many diseases and is used to treat diseases such as neural degenerative disorders [20, 25], ciliary and heart dysfunction [59, 30], dementia [60], DM [61], lung injury [8], chronic kidney disease [62], spinal injury [53] and cancer [56]. The gene discussed is HDAC6; the disease is cancer.